Publication:
Tocilizumab for treating severe COVID-19 pneumonia refractory to combined hydroxychloroquine, lopinavir plus ritonavir, and favipiravir: A case series

Suggested Citation

Manoon Surabotsophon, Yingyot Klai-On, Vipa Thanachartwet, Sirote Khunapornphairote, Supat Chamnanchanunt, Theerapat Racharak, Wannada Laisuan, Duangjai Sahassananda, Samlee Hapunna, Somjit Jinapuk, Suthee Leelasetakul, Varunee Desakorn Tocilizumab for treating severe COVID-19 pneumonia refractory to combined hydroxychloroquine, lopinavir plus ritonavir, and favipiravir: A case series. Clinical Case Reports. Vol.8, No.12 (2020), 3264-3277. doi:10.1002/ccr3.3407 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/60534

Research Projects

Organizational Units

Authors

Journal Issue

Thesis

Availability

Collections